Polymerized Type I Collagen Downregulates STAT-1 Phosphorylation Through Engagement with LAIR-1 in Circulating Monocytes, Avoiding Long COVID.
Olivares-Martínez, Elizabeth, Hernández-Ramírez, Diego Francisco, Núñez-Álvarez, Carlos Alberto et al.·International journal of molecular sciences·2025
Researchers tested a treatment called polymerized type I collagen (PTIC) in COVID-19 patients and found it may help reduce excessive inflammation by calming down immune cells called monocytes. The treatment appeared to improve breathing, reduce fatigue, chest pain, and cough in both the acute phase and long-term recovery from COVID-19. This finding could potentially be relevant for patients with long COVID or ME/CFS, which involve similar inflammatory problems.